

27 Oct 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218205

29 Aug 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/pfizer-discontinue-low-dose-attr-drug-vyndaqel-us-ahead-2028-patent-loss

15 Oct 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218365

30 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/30/2938591/0/en/BridgeBio-Shares-Data-on-Serum-TTR-Increase-When-Switching-Participants-from-Placebo-and-Tafamidis-to-Acoramidis-in-ATTRibute-CM-and-its-Open-Label-Extension.html

21 Aug 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218205

25 Jun 2024
// Angus Liu FIERCE PHARMA
https://www.fiercepharma.com/pharma/alnylam-ceo-touts-big-win-scenario-amvuttra-closely-watched-heart-disease-trial